Post partum hemorrhage - Nursing Case Study
Pathophysiology
• Primary mechanism: Uterine atony, the failure of the uterus to contract effectively after delivery, is the leading cause of postpartum hemorrhage. Without adequate contraction, the uterine blood vessels remain open, leading to significant blood loss.
• Secondary mechanism: Retained placental tissue can prevent the uterus from contracting properly and maintaining hemostasis. Fragments of the placenta left in the uterus can cause continuous bleeding until they are expelled or removed.
• Key complication: If not promptly addressed, postpartum hemorrhage can lead to hypovolemic shock, characterized by decreased blood pressure and inadequate organ perfusion, which can be life-threatening for the mother.
Patient Profile
Demographics:
32-year-old female, school teacher
History:
• Key past medical history: History of anemia, previous cesarean section
• Current medications: Prenatal vitamins, iron supplements
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Excessive bleeding postpartum
• Key symptoms: Weakness, dizziness, shortness of breath, lightheadedness
• Vital signs: Blood pressure 90/60 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F
Section 1
Change in Patient Status:
After initial interventions to manage the postpartum hemorrhage, including uterine massage and administration of oxytocin to promote uterine contraction, the patient's bleeding persists. Her vital signs reveal increased hemodynamic instability: blood pressure drops further to 85/55 mmHg, heart rate elevates to 120 bpm, and respiratory rate remains at 24 breaths per minute. The patient appears increasingly pale and reports worsening dizziness and shortness of breath. A focused bedside assessment reveals that the uterine fundus is still boggy and not firming up as expected. Despite the administration of uterotonics, there is no significant improvement in uterine tone, suggesting ongoing uterine atony.
The patient's lab results return, indicating a hemoglobin level of 7.5 g/dL, significantly lower than the pre-delivery level, and a hematocrit of 23%, confirming the severity of blood loss. This further raises the concern for hypovolemic shock due to insufficient circulating blood volume. The healthcare team decides to initiate more aggressive interventions, including the administration of intravenous fluids and blood products, to stabilize the patient's condition. Continuous monitoring is crucial to assess the effectiveness of these interventions and to determine if surgical intervention, such as a dilation and curettage to remove retained placental tissue, may be necessary to control the bleeding. The patient's worsening status necessitates increased vigilance to prevent progression to more severe complications such as multi-organ dysfunction.
Section 2
As the clinical team continues to address the postpartum hemorrhage, the patient's condition remains precarious. Despite the administration of intravenous fluids and blood products, the patient's blood pressure remains unstable, hovering around 88/58 mmHg, and her heart rate has increased slightly to 125 bpm. Her respiratory rate is 26 breaths per minute, indicating increased respiratory effort. Auscultation reveals clear lung fields, but the patient's oxygen saturation has decreased to 92% on room air, prompting the initiation of supplemental oxygen to maintain adequate tissue perfusion.
In the midst of these efforts, new diagnostic results arrive, providing further insight into the patient's condition. A repeat hemoglobin level shows a slight improvement to 8.0 g/dL after transfusion, but the ongoing blood loss raises concerns about the balance between hemorrhage and replacement. A coagulation profile reveals prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), suggesting the development of coagulopathy, possibly due to consumptive coagulopathy secondary to massive transfusion or disseminated intravascular coagulation (DIC). These findings necessitate the consideration of additional blood products, such as fresh frozen plasma, to correct coagulopathy and facilitate clot formation.
Recognizing the need for swift action to prevent further deterioration, the healthcare team discusses the potential need for surgical intervention. The persistent boggy uterus, despite uterotonics, signals that retained placental fragments or uterine inversion might be contributing to the unrelenting bleeding. The decision is made to prepare the patient for an exploratory procedure to identify and address the underlying cause of the hemorrhage. This intervention may involve dilation and curettage or even more invasive surgical measures, depending on intraoperative findings. The clinical team remains vigilant, closely monitoring the patient's hemodynamic status and laboratory values to guide ongoing management decisions and prevent the progression to more severe complications.
Section 3
As preparations for the exploratory procedure progress, the patient's condition takes a concerning turn. Despite receiving supplemental oxygen, her oxygen saturation continues to hover at 92%, and her respiratory rate has increased to 28 breaths per minute, indicating mounting respiratory distress. The team reassesses her cardiovascular status, noting that her blood pressure has dropped further to 84/54 mmHg, and her heart rate has climbed to 130 bpm. These changes suggest worsening perfusion, potentially due to the ongoing hemorrhage and the body's compensatory mechanisms being overwhelmed.
New diagnostic results arrive, offering critical insights into the evolving situation. A repeat coagulation profile shows further prolongation of PT and aPTT, with a notable decrease in fibrinogen levels to 150 mg/dL, reinforcing the suspicion of consumptive coagulopathy. Additionally, the patient's platelet count has fallen to 75,000/mm³, indicating thrombocytopenia, which could complicate surgical intervention and necessitate platelet transfusion. These findings underscore the urgency of correcting the coagulopathy and stabilizing the patient's hemodynamic status before proceeding to surgery.
The clinical team urgently initiates the administration of fresh frozen plasma and platelet transfusions to address the coagulopathy and support clot formation. Careful monitoring of the patient's response to these interventions is crucial, as the team balances the risk of further bleeding against the possibility of thrombosis. As the team prepares for the surgical procedure, they remain acutely aware of the potential for new complications, such as acute respiratory distress syndrome (ARDS) or multi-organ failure, should the patient's condition continue to deteriorate. The immediate focus is on stabilizing the patient sufficiently to tolerate the necessary surgical exploration, with continuous reassessment guiding each step of the process.
Section 4
As the team administers the fresh frozen plasma and platelet transfusions, they observe the patient closely for any signs of improvement or further deterioration. Despite the urgency, the interventions appear to have a stabilizing effect initially. The patient's heart rate begins to decrease slightly, settling around 120 bpm, and her blood pressure shows a modest improvement to 90/58 mmHg. Her respiratory rate decreases to 24 breaths per minute, with oxygen saturation climbing to 94%, suggesting a partial response to the treatment. However, the team remains vigilant, knowing that these changes could be temporary without further intervention to control the underlying hemorrhage.
A subsequent set of lab results provides a mixed picture of the patient’s coagulation status. The fibrinogen levels have risen to 180 mg/dL, and the PT and aPTT show slight improvements, indicating a positive response to the transfusions. However, the platelet count remains low at 80,000/mm³, highlighting the need for ongoing transfusion support. In addition to these findings, the team notes an increased lactate level of 4.2 mmol/L, a marker of tissue hypoperfusion and possible lactic acidosis, which could signal the early stages of organ dysfunction. This reinforces the urgency of the situation and the need to expedite surgical intervention.
As preparations for surgery continue, the team considers the risk of acute respiratory distress syndrome (ARDS) given the patient's recent respiratory distress and continued need for oxygen support. They ensure that the anesthesia team is aware of her fragile respiratory status and prepare for possible ventilatory support during and after the procedure. The team’s immediate focus is to stabilize her hemodynamically and correct the coagulopathy as much as possible before proceeding to surgical exploration. The clinical reasoning now centers around carefully balancing the interventions to prevent further complications while preparing for the critical surgical step that could ultimately address the underlying cause of the hemorrhage.
Section 5
As the surgical team prepares for the procedure, the patient's condition takes a concerning turn. Despite the initial stabilization, her heart rate begins to climb again, reaching 130 bpm, while her blood pressure drops slightly to 85/55 mmHg. Her oxygen saturation falls back to 91%, and her respiratory rate increases to 28 breaths per minute, suggesting that the respiratory support is becoming less effective. The team quickly reassesses her fluid status and considers additional blood product transfusions to support her hemodynamic stability.
Meanwhile, new diagnostic results arrive, further complicating the scenario. A repeat complete blood count shows a slight decrease in hemoglobin to 7.8 g/dL, indicating ongoing blood loss despite transfusion efforts. Additionally, a chest X-ray ordered due to the respiratory concerns reveals developing bilateral infiltrates, raising suspicion for early acute respiratory distress syndrome (ARDS). This finding prompts the anesthesia and critical care teams to discuss the potential requirement for invasive ventilatory support during surgery, as well as strategies to manage ARDS post-operatively.
The increased lactate level, now at 5.0 mmol/L, corroborates the signs of tissue hypoperfusion and escalates the urgency for surgical intervention. The team decides to expedite the transfer to the operating room, prioritizing the control of hemorrhage to prevent further deterioration. They continue to administer supportive therapies, including additional platelets and fresh frozen plasma, to optimize her coagulation status. These developments necessitate a delicate balance of interventions, as the team strives to stabilize the patient for surgery while preventing further complications in her respiratory and cardiovascular systems.